NO984760L - Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction - Google Patents

Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction

Info

Publication number
NO984760L
NO984760L NO984760A NO984760A NO984760L NO 984760 L NO984760 L NO 984760L NO 984760 A NO984760 A NO 984760A NO 984760 A NO984760 A NO 984760A NO 984760 L NO984760 L NO 984760L
Authority
NO
Norway
Prior art keywords
osmolyte
inflammation
infection
treatment
immune dysfunction
Prior art date
Application number
NO984760A
Other languages
Norwegian (no)
Other versions
NO984760D0 (en
Inventor
Dieter Houssinger
Original Assignee
Dieter Houssinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dieter Houssinger filed Critical Dieter Houssinger
Publication of NO984760D0 publication Critical patent/NO984760D0/en
Publication of NO984760L publication Critical patent/NO984760L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Terapi og egnede preparater omfattende en effektiv mengde av en osmolytt som er i stand til å behandle effektene av en infeksjon, en inflammasjon eller immundysfunksjon.Therapy and suitable compositions comprising an effective amount of an osmolyte capable of treating the effects of an infection, inflammation or immune dysfunction.

NO984760A 1996-04-12 1998-10-12 Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction NO984760L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601395A SE9601395D0 (en) 1996-04-12 1996-04-12 New therapeutic treatment 1
PCT/EP1997/001862 WO1997038686A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction

Publications (2)

Publication Number Publication Date
NO984760D0 NO984760D0 (en) 1998-10-12
NO984760L true NO984760L (en) 1998-10-12

Family

ID=20402174

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984760A NO984760L (en) 1996-04-12 1998-10-12 Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction

Country Status (7)

Country Link
EP (1) EP0910361A1 (en)
JP (1) JP2000508331A (en)
AU (1) AU2697197A (en)
CA (1) CA2251204A1 (en)
NO (1) NO984760L (en)
SE (1) SE9601395D0 (en)
WO (1) WO1997038686A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
US6926911B1 (en) 1998-12-22 2005-08-09 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
AU771984B2 (en) * 1998-12-22 2004-04-08 University Of North Carolina At Chapel Hill, The Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
ES2233630T3 (en) * 2000-04-12 2005-06-16 Bitop Aktiengesellschaft Fur Biotechnische Optimierung USE OF COMPATIBLE SOLUTES AS SUBSTANCES WITH RADICAL SWEEPING PROPERTIES.
CA2386985A1 (en) * 2000-08-11 2002-02-21 The Lawson Health Research Institute Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
AP2007004084A0 (en) * 2005-01-05 2007-08-31 Fisher Cormack & Botha Taurine synthesis production and utility as a medicine
EP2242489A1 (en) 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
EP1858519B1 (en) 2005-03-12 2013-02-20 Bitop Aktiengesellschaft Für Biotechnische Optimierung Ectoin and/or hydroxyectoin for the prevention and treatment of inflammatory bowel diseases
ATE540690T1 (en) 2005-04-27 2012-01-15 Jallal Messadek INSULIN COMBINATIONS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728444A (en) * 1971-04-28 1973-04-17 Stanley Drug Products Inc Method and compositions for inducing resistance to bacterial infections
AU7584891A (en) * 1990-03-19 1991-10-21 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
TW282398B (en) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
US5516798A (en) * 1994-10-11 1996-05-14 North Carolina State University Method for treating diarrhea and a composition therefor

Also Published As

Publication number Publication date
NO984760D0 (en) 1998-10-12
WO1997038686A1 (en) 1997-10-23
EP0910361A1 (en) 1999-04-28
AU2697197A (en) 1997-11-07
JP2000508331A (en) 2000-07-04
CA2251204A1 (en) 1997-10-23
SE9601395D0 (en) 1996-04-12

Similar Documents

Publication Publication Date Title
NO982311L (en) Compositions and methods for the prevention and treatment of oral muscocyte
TR200101481T2 (en) Cancer treatment composition and method using natural herbal essential oils.
NO20024011L (en) Carbohydrate formulation (prebiotic aid) to improve the immune system
DK1039912T3 (en) Angiostatic agents and preparations for the treatment of GLC1A glaucoma
NO984760L (en) Use of an osmolyte in the treatment of effects caused by an infection, inflammation or immune dysfunction
FR2759581B1 (en) TREATMENT DEVICE, IN PARTICULAR WITH MOXA, OF THE ACUPRESSURE TYPE
ES2172654T3 (en) USE OF NSAID FOR THE TREATMENT OF SCALE CARCINOMAS OF THE ORAL OR OROPHARING CAVITY.
DK0751789T3 (en) Gel for treating skin diseases and for disinfecting the skin
NO940266L (en) Internal radiation damage
ATE207342T1 (en) SUBSTANCES OR COMBINATIONS OF ACTIVE INGREDIENTS AND PREPARATIONS EFFECTIVE AGAINST SKIN AGING
AR008799A1 (en) VACCINE COMPOSITION TO PREVENT OR TREAT MALARIA; USE OF SUCH COMPOSITION TO PREPARE DRUGS AND METHOD FOR SUCH PROPHYLAXIS AND SUCH TREATMENT
NO975858D0 (en) Use of an extract of Cimicifuga racemosa
IL132214A0 (en) Use of zinc hyaluronate against peptic ulcer
DK0988040T3 (en) Use of glucosamine and glucasamine derivatives for rapid relief of itching or localized pain
DK0563085T3 (en) Hitherto unknown preparations
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
CA2408541A1 (en) Treating eczema and/or psoriasis
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
MXPA01011924A (en) Methods and compositions for modulating immune response and for the treatment of inflammatory disease.
NO984160L (en) Procedure for the treatment or prevention of interstitial cystitis
NO984920L (en) Preparations comprising a nitron compound for use in the treatment of ocular inflammation
DK0722325T3 (en) Preparation for the treatment or prevention of herpes
NO970185L (en) Use of (S) -adenosyl-L-methionine (SAMe) and its physiologically compatible salts for the treatment of reperfusion injury triggered by temporal-focal ischemia
DE60044539D1 (en) VACCINATES CONTAINING LACTOBACILLI FOR THE TREATMENT OF PROSTATE INFLAMMATION AND PROSTATE HYPERPLASIA
MD916G2 (en) Ungent for stomatologic deseases treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application